期刊文献+

乳腺癌48例新辅助化疗前后超声声像图的变化

Ultrasound changes of 48 patients with advanced local breast cancer before and after neoadjuvant chemotherapy
下载PDF
导出
摘要 目的探讨超声对乳腺癌新辅助化疗疗效评价的意义。方法48例进行新辅助化疗的乳腺癌患者,均于化疗前、化疗后对乳腺癌原发灶进行声像图的观察及分析。结果48例患者新辅助化疗后超声检查显示,化疗前后原发灶明显缩小甚至消失,原发灶内血流丰富程度降低或消失;最高流速(Vmax),和阻力指数(RI)降低(P<0.01,P<0.01);相应病例腋窝淋巴结转移灶也呈现上述表现。结论利用对乳腺病灶化疗前后的超声检查,可为新辅助化疗提供有效、安全的疗效观察手段。 Objective To investigate the value of ultrasound changes of breast cancer in evaluation of therapeutic effect of neoadjuvant chemo-therapy in locally advanced breast cancer.Methods The primarly lesion and axillary nodes of48 patients with breast cancer were examined by col-or doppler ultrasound before and after neoadjuvant chemotherapy.Results After neoadjuvant chemotherapy, the primarly lesion and its blood vol-ume significantly decreased and even disappeared, Vmax and RI also reduced. The same changes were observed in the metastatic lymph nodes.Conclusion Ultrasonography is an effective non -invasive way for the evaluation of results of neoadjuvant chemotherapy.
出处 《临床和实验医学杂志》 2006年第9期1300-1301,共2页 Journal of Clinical and Experimental Medicine
关键词 超声检查 乳腺癌 新辅助化疗 Ultrasound Bbreast cancer Neoadjuvant chemotherapy
  • 相关文献

参考文献4

  • 1[1]Adler DD,Carson PL,RubinJM,et al.Dopplor ultrosound color flow imaging in the study of breast cancer:preliminary findings[J].Ultrosound Med Biol,1990,16(6):553-559.
  • 2[3]Denekamp J.Vascular attack as the rapeutic strategy for cancer[J].Cancer Metasrasis Rev,1990,9(3):267-282.
  • 3杨越,刘跃英.乳腺癌新辅助化疗[J].昆明医学院学报,2003,24(1):108-111. 被引量:7
  • 4[6]Garces CA,Cance WG.Neoadjuvant chemotherapy of breast cancer[J].Am Surg,2004,70(7):565-569.

二级参考文献12

  • 1[1]FISHER B, SAFFET E A, RUDOCK C,et al. Effect of local or systemic treatment prior to primary tumour removal on the production and response to a serum growth stimulating factor in mice[J]. Cancer Res ,1989,49:2002
  • 2[2]GOLDMAN J H,COLDMAN A J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate[J].Cancer Treat Rep, 1979,63:1727
  • 3[3]KOSCIELNY S, TUBIANA M, LE M G,et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination[J]. Br J Cancer ,1984, 49:709
  • 4[4]HAYWARD J L, CARBONE P P, HEUSON J C, et al. Assessment of response to therapy in advanced breast cancer[J]. Br J Cancer ,1997,35:292
  • 5[5]CAYRE A, CACHIN F, MAUBLANT J,et al.Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression[J]. Int J Oncol ,2002,20(5):1049
  • 6[6]VAN DER HAGE J A, VAN DER VELDER C J H, JUAIEN J P,et al. Preoperative chemotherapy in primary operable breast cancer:results from the european organization for research and treatment of cancer trial 10902[J]. J Clin Oncol ,2001,19(22):4224
  • 7[7]FISHER B,BRYANT J, WOLMARK N. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer[J]. J Clin Oncol, 1998,16(8):2672
  • 8[8]MAMOUNAS E P. NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel[J]. Oncology (Huntingt) ,1997,11(6 Suppl 6):37
  • 9[9]MAMOUNAS E P, FISHER B. Preoperative (Neoadjuvant) chemotherapy in patients with breast cancer[J]. Seminars in Oncol ,2001,28(4):389
  • 10[10]THAMAS E, BUZDAR A, THERIAULT R, et al. Role of paclitaxel in adjuvant therapy of operable breast cancer: preliminary results of prospective randomized clinical trial[J]. Proc Am Soc Clin Oncol, 2000,19(74): 285

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部